CSI Market
Sign In | Register

Eiger Biopharmaceuticals Inc (EIGR) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access EIGR Annual Balance Sheets →
From Eiger Biopharmaceuticals Inc through Dec 31 2022, shifts in Dec 31 2023's assets and liabilities provide insight into the company's capital structure and financial stability.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent25.44
Cash & Short-term Investments25.00
Accounts receivable1.68
Inventories1.56
Other Current Assets0.00
Prepaid Expense And Other Assets Current9.16
Total Current Assets37.84
Equipment/Property/Plant Net0.63
Other Assets, Noncurrent0.36
Debt Securities Current-
Operating Lease Right Of Use Asset-
Total Assets38.83
Liabilities
Accounts Payable, Current AC2.12
Accrued Liabilities, Current AC9.97
Long-term Debt, Current Maturities LO41.12
Other Liabilities, Current0.00
Taxes Payable0.00
Total Current Liabilities53.28
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.08
Operating Lease Liability Noncurrent-
Total Liabilities53.28
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock497.87
Retained Earnings / Accumulated Deficit-512.16
Other Equity-0.17
Common Stockholder's Equity-14.46
Total Stockholder's Equity-14.46
Liabilities & Stockholder's Equity38.83
4 historic quarters locked

Sign in to unlock the full Eiger Biopharmaceuticals Inc balance sheet history.

Sign In Create Free Account

About Eiger Biopharmaceuticals Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001628280-24-015297

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.